跳至主要内容
临床试验/ACTRN12623001278628
ACTRN12623001278628尚未招募4 期

A Double Blinded Three Arm Randomized Controlled Trial of Placebo, Intraarticular Corticosteroid Injection and Genicular Nerve Block for the Treatment of Symptomatic Knee Osteoarthritis

St George Hospital0 个研究点目标入组 132 人开始时间: 2023年12月7日最近更新:
适应症

试验速览

阶段
4 期
状态
尚未招募
入组人数
132

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • Age >= 18 years
  • Able to consent
  • Has readily accessible XRs of the knees of less than 12 months duration
  • Knee OA as defined by ACR classification criteria
  • Chronicity of pain as defined by 4 or more on VAS (1-10) on most days for at least 3 months
  • Kellgren-Lawrence score of II or III
  • Intraarticular steroid injection to the knee naive

排除标准

  • Inflammatory arthritis
  • Allergy to intervention compounds
  • Cognitive impairment or short term memory loss
  • Planned orthopaedic surgery within 6 months

研究者

相似试验